A Prospective, Randomized, Controlled, Study Evaluating EVICEL Fibrin Sealant as an Adjunct to Hemostasis During, Abdominal, Retroperitoneal or Pelvic Surgery in Pediatric Patients
Phase of Trial: Phase IV
Latest Information Update: 22 Mar 2017
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- Sponsors Ethicon
- 18 Jan 2017 Planned End Date changed from 1 Nov 2016 to 1 Feb 2018.
- 18 Jan 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2017.
- 17 Aug 2015 Planned End Date changed from 1 Nov 2015 to 1 Nov 2016, as reported by ClinicalTrials.gov.